Dupilumab in children with moderate‐to‐severe asthma: A cost utility analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dupilumab in children with moderate‐to‐severe asthma: A cost utility analysis

Published:2022-06-13 Issue:10 Volume:57 Page:2313-2319
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatric Pulmonology

Author:

Buendía Jefferson A.¹^ORCID,Patiño Diana G.¹

Affiliation:

1. Research Group in Pharmacology and Toxicology “INFARTO”. Department of Pharmacology and Toxicology University of Antioquia Medellin Colombia

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.26033

Reference29 articles.

1. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

2. Trends in worldwide asthma prevalence

3. The prevalence of severe refractory asthma

4. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention; 2021. https://ginasthma.org/

5. Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Updated Reappraisal of Dupilumab in Children and Adolescents with Severe Asthma;Children;2024-07-11

2. Genotype‐driven asthma prescribing of inhaled corticosteroids and long‐acting β2‐agonist: A cost‐effectiveness analysis;Pediatric Pulmonology;2024-04-25

3. Cost-utility analysis of prenatal supplementation with long-chain n-3 fatty acids to reduce the incidence of wheezing and asthma in neonates;Journal of Asthma;2024-03-04

4. The role and molecular mechanisms of alternative splicing of Th2-cytokines IL-4 and IL-5 in atopic bronchial asthma;Биохимия;2023-12-15

5. Role and Molecular Mechanisms of Alternative Splicing of Th2-Cytokines IL-4 and IL-5 in Atopic Bronchial Asthma;Biochemistry (Moscow);2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3